Status:
COMPLETED
Shortening Duration of Antiarrhythmic Medication for SVT in Infants
Lead Sponsor:
Tampere University Hospital
Collaborating Sponsors:
Helsinki University Central Hospital
Kuopio University Hospital
Conditions:
Supraventricular Tachycardia
Eligibility:
All Genders
Up to 6 years
Brief Summary
The infants diagnosed with SVT are treated with antiarrhythmic medication to prevent the recurrence of SVT. This prospective observational cohort study evaluates efficacy and safety of shortening dura...
Eligibility Criteria
Inclusion
- Age 6 months or less
- Documented SVT due to AVRT or AVNRT
Exclusion
- Age \> 6 months
- Ectopic atrial tachycardia
- Atrial flutter
- Atrial fibrillation
- Permanent junctional reciprocating tachycardia
Key Trial Info
Start Date :
April 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2024
Estimated Enrollment :
107 Patients enrolled
Trial Details
Trial ID
NCT04837261
Start Date
April 15 2021
End Date
January 31 2024
Last Update
November 20 2025
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Central Finland Central Hospital
Jyväskylä, Central Finland, Finland, 40620
2
Kajaani Central Hospital
Kajaani, Kainuu, Finland, 87300
3
Hämeenlinna Central Hospital
Hämeenlinna, Kanta-Häme, Finland, 13530
4
Kokkola Central Hopsital
Kokkola, Keski-Pohjanmaa, Finland, 67200